Concepedia

Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction

David W. Hoskin, Teresa Reynolds, Jonathan Blay

Cancer Immunology Immunotherapy · 1994 · 15 citations · 29 references

DOIFull text

Open access

Concepts

References

29

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

, , +15

Transforming growth factor beta

Anita B. Roberts, Michael B. Sporn · SpringerReference · 2011 · 1.9K citations

, , +16

Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Oberdan Léo, M Foo, David H. Sachs et al. · Proceedings of the National Academy of Sciences · 1987 · 1.6K citations · Full text

, , +16

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

William H. West, Kurt W. Tauer, John R. Yannelli et al. · New England Journal of Medicine · 1987 · 1.2K citations

, , +16

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

Joseph H. Phillips, Lewis L. Lanier · The Journal of Experimental Medicine · 1986 · 694 citations · Full text

, , +12